press information

MOOG INC., EAST AURORA, NEW YORK 14052   TEL-716/652-2000   FAX -716/687-4457

release date      Immediate                          contact  Ann Marie Luhr
                  October 30, 2008                            716-687-4225


                 MOOG REPORTS YEAR-END EARNINGS PER SHARE UP 18%


Moog Inc.  (NYSE:  MOG.A and MOG.B) today announced net earnings of $119 million
and  earnings per share of $2.75,  an increase of 18% over last year.  Sales for
the year of $1.903  billion were up $345 million or 22% over the previous  year.
Sales  increases  were  very  strong  in all  five  of the  Company's  reporting
segments.

Fourth  quarter  net  earnings  increased  18% over last year to $31.7  million.
Earnings  per share for the  quarter  were 73 cents,  18% higher than last year.
Total sales for the quarter of $491 million were up 19%.

In the Aircraft  segment,  sales for the year were up 15% to $673  million.  The
sales increase was mostly in military aircraft where revenues were $402 million.
The sales increase was driven by accelerating production work on the V-22 Osprey
rotorcraft,  increased development activity on the F-35 Joint Strike Fighter and
strong military aftermarket sales.

Commercial  aircraft sales for the year of $271 million were up 4%. The increase
was in sales to business jet manufacturers,  principally Gulfstream, Bombardier,
and Hawker  Beechcraft.  The Company recently announced that it is supplying the
entire  flight  control  system  for the new  Gulfstream  G250.  Sales to Boeing
Commercial were $76 million for the year, down from last year and the commercial
aftermarket revenues came in 6% below last year.

For the fourth  quarter,  Aircraft  sales of $176  million were up 10%. It was a
strong quarter in sales on the F-35 and the V-22. The military  aftermarket  had
record  sales of $39 million.  On the  commercial  side,  the only growth was in
business  jets as a result of  increased  production  on the Hawker 4000 and the
Challenger 300.



In the Space and  Defense  segment,  sales of $253  million  were up 37% for the
year. Moog's  traditional  products in this segment are controls for satellites,
launch  vehicles,  and  strategic  and  tactical  missiles,  and these  products
provided  the solid base of sales.  The growth in the year was  provided  by the
Constellation  program and two acquisitions.  Constellation,  which is the Space
Shuttle  replacement  program,  generated $24 million in sales in the year.  The
QuickSet  acquisition  through  its Driver  Vision  Enhancer  program  added $33
million in sales of mechanisms for MRAP vehicles.  The CSA acquisition came late
in the year and added another $6 million in sales.

Fourth quarter Space and Defense sales were $62 million, up 35% from a year ago.
In the quarter, the growth was also driven by the Constellation  program and the
two recent acquisitions.

Moog's Industrial  Systems segment had sales for the year of $532 million, a 22%
increase.  Three markets - motion  simulators,  metal-forming  presses and steel
mill  equipment  led the  charge  for the fiscal  year with  growth  percentages
ranging  from 33% to 56%.  These  three  markets  provided  total  sales of $174
million.  In addition,  plastics controls grew to $77 million.  Power generation
was up to $50 million.

The fourth  quarter was also  strong in the  Industrial  segment.  Sales of $136
million  were up 23%.  Once again,  the  strongest  growth in the quarter was in
motion simulators, metal-forming machines and steel mill equipment.

In the Components  Group,  sales for the year were up in every product category.
The total at $341 million was up 20%.  Growth in the aircraft market came on the
Guardian System, which protects aircraft from shoulder-fired missiles and on the
Multi-Spectral  Targeting  System used on the  Predator  Unmanned  Air  Vehicle.
Deliveries of slip ring systems  continued to be strong for the Abrams Tank, the
Bradley Fighting Vehicle, and the Stryker Mobile Gun System. Marine sales of $46
million were up 53%, reflecting increased oil exploration.

Fourth quarter  Components  Group  sales were $90 million,  up 23% from the year
previous.  Products for military aircraft,  space and defense equipment, and the
marine market were all particularly strong in the quarter.

For the year, the Medical Devices segment  generated sales of $103 million.  The
total included pump sales of $38 million,  sales of  administration  sets at $35
million and $30 million in sales of  sensors,  hand pieces and other  associated
equipment.

For the quarter, sales in Medical Devices of $26 million were up 11% from a year
ago. In the quarter,  higher sales reflected an increase in administration sets,
sensor sales and cataract hand pieces.

Year-end  consolidated  backlog of $862 million was up $87 million or 11% from a
year ago.



The  Company  updated its  guidance  for fiscal  2009.  Fiscal '09 sales are now
forecast  in a range of $1.995  billion  to $2.035  billion.  Net  earnings  are
forecast in the range  between $132 million and $136  million.  The midrange net
earnings of $134  million  would  generate  earnings  per share of $3.08,  a 12%
increase over the $2.75 reported for fiscal '08.

"Fiscal '08 was another great year for our Company"  said R. T. Brady,  Chairman
and CEO.  "This was our  fourteenth  consecutive  year of growth in earnings per
share.  This year the increase was 18%. We achieved  these  results while making
substantial  investments in R&D particularly in our aircraft  business.  We were
helped by big increases in the Constellation  program and strong markets for our
Industrial products and for the Components Group. The QuickSet acquisition was a
big  contributor  through its Driver Vision Enhancer  program.  During our third
quarter,  we expanded our credit  availability  and we entered the current tight
credit market with over $500 million of cash and available credit facilities. We
expect to encounter a challenging economic period in fiscal '09, but our product
portfolio provides us with a very strong hand to play. Our aerospace and defense
business  will not be affected and we believe that our medical  devices and many
of our industrial  products will  experience  very little  recessionary  impact.
We're  optimistic  that  fiscal  '09 will be the  fifteenth  year of  growth  in
earnings per share."

Moog Inc. is a worldwide  designer,  manufacturer,  and  integrator of precision
control components and systems. Moog's high-performance systems control military
and  commercial  aircraft,  satellites  and  space  vehicles,  launch  vehicles,
missiles,   automated  industrial  machinery,   marine  and  medical  equipment.
Additional information about the Company can be found at www.moog.com.



Cautionary Statement

Information  included  herein or incorporated by reference that does not consist
of historical  facts,  including  statements  accompanied by or containing words
such as "may," "will," "should," "believes,"  "expects,"  "expected," "intends,"
"plans,"   "projects,"    "estimates,"   "predicts,"   "potential,"   "outlook,"
"forecast,"   "anticipates,"   "presume"  and   "assume,"  are   forward-looking
statements. Such forward-looking statements are made pursuant to the safe harbor
provisions  of the  Private  Securities  Litigation  Reform  Act of 1995.  These
statements are not guarantees of future  performance  and are subject to several
factors, risks and uncertainties,  the impact or occurrence of which could cause
actual results to differ  materially from the expected results  described in the
forward-looking  statements.  These important  factors,  risks and uncertainties
include (i)  fluctuations in general  business  cycles for commercial  aircraft,
military  aircraft,  space and defense  products,  industrial  capital goods and
medical  devices,  (ii) our  dependence on government  contracts that may not be
fully  funded  or may be  terminated,  (iii) our  dependence  on  certain  major
customers,  such as The Boeing  Company and Lockheed  Martin,  for a significant
percentage of our sales,  (iv) the possibility  that the demand for our products
may be reduced if we are unable to adapt to  technological  change,  (v) intense
competition  which may require us to lower prices or offer more favorable  terms
of sale, (vi) our significant indebtedness which could limit our operational and
financial  flexibility,  (vii) the possibility that new product and research and
development  efforts  may not be  successful  which  could  reduce our sales and
profits,  (viii) increased cash funding  requirements  for pension plans,  which
could occur in future years based on  assumptions  used for our defined  benefit
pension  plans,  including  returns on plan assets and  discount  rates,  (ix) a
write-off  of all or part of our  goodwill,  which  could  adversely  affect our
operating  results and net worth and cause us to violate  covenants  in our bank
agreements,  (x) the potential for substantial fines and penalties or suspension
or  debarment  from  future  contracts  in  the  event  we do  not  comply  with
regulations  relating to defense  industry  contracting,  (xi) the potential for
cost overruns on  development  jobs and fixed price  contracts and the risk that
actual results may differ from estimates used in contract accounting,  (xii) the
possibility  that our  subcontractors  may  fail to  perform  their  contractual
obligations, which may adversely affect our contract performance and our ability
to obtain  future  business,  (xiii) our ability to  successfully  identify  and
consummate  acquisitions,  and integrate the acquired  businesses  and the risks
associated  with  acquisitions,  including  that the acquired  businesses do not
perform  in  accordance  with  our  expectations,  and  that we  assume  unknown
liabilities  in  connection  with the acquired  businesses  for which we are not
indemnified, (xiv) our dependence on our management team and key personnel, (xv)
the  possibility  of a  catastrophic  loss of one or  more of our  manufacturing
facilities, (xvi) the possibility that future terror attacks, war or other civil
disturbances could negatively impact our business, (xvii) that our operations in
foreign  countries  could  expose us to political  risks and adverse  changes in
local,  legal,  tax  and  regulatory  schemes,   (xviii)  the  possibility  that
government  regulation  could limit our ability to sell our products outside the
United  States,  (xix) product  quality or patient safety issues with respect to
our medical devices business that could lead to product recalls, withdrawal from
certain  markets,  delays  in  the  introduction  of  new  products,  sanctions,
litigation,  declining  sales or actions  of  regulatory  bodies and  government
authorities, (xx) the impact of product liability claims related to our products
used in applications  where failure can result in significant  property  damage,
injury  or death and in damage to our  reputation,  (xxi) the  possibility  that
litigation  may  result  unfavorably  to us,  (xxii) our  ability to  adequately
enforce our intellectual  property rights and the possibility that third parties
will assert intellectual property rights that prevent or restrict our ability to
manufacture, sell, distribute or use our products or technology, (xxiii) foreign
currency fluctuations in those countries in which we do business and other risks
associated  with  international  operations,  (xxiv) the cost of compliance with
environmental  laws,  (xxiv)  the  risk of  losses  resulting  from  maintaining
significant amounts of cash and cash equivalents at financial  institutions that
are in excess of amounts insured by governments,  (xxv) the inability to utilize
amounts available to us under our credit  facilities given  uncertainties in the
credit  markets  and (xxvi) our  customer's  inability  to pay us due to adverse
economic  conditions or their inability to access available credit.  The factors
identified above are not exhaustive.  New factors,  risks and  uncertainties may
emerge  from time to time that may affect the  forward-looking  statements  made
herein. Given these factors, risks and uncertainties, investors should not place
undue reliance on forward-looking statements as predictive of future results. We
disclaim any obligation to update the  forward-looking  statements  made in this
report.





                                    MOOG INC.
                       CONSOLIDATED STATEMENTS OF EARNINGS
                  (dollars in thousands, except per share data)


                                               Three Months Ended                 Twelve Months Ended
                                        September 27,     September 29,     September 27,      September 29,
                                            2008              2007              2008               2007
                                       ---------------   ---------------   ---------------    ---------------
                                                                                  
Net sales                              $       490,846   $       413,415   $     1,902,666    $     1,558,099
Cost of sales                                  337,388           275,206         1,293,452          1,028,852
                                       ---------------   ---------------   ---------------    ---------------
Gross profit                                   153,458           138,209           609,214            529,247
                                       ---------------   ---------------   ---------------    ---------------

Research and development                        28,913            26,411           109,599            102,603
Selling, general and administrative             75,302            66,112           294,936            252,173
Interest                                         9,683             9,123            37,739             29,538
Other                                              651               197            (1,095)             1,182
                                       ---------------   ---------------   ---------------    ---------------
                                               114,549           101,843           441,179            385,496
                                       ---------------   ---------------   ---------------    ---------------

Earnings before income taxes                    38,909            36,366           168,035            143,751

Income taxes                                     7,255             9,557            48,967             42,815
                                       ---------------   ---------------   ---------------    ---------------

Net earnings                           $        31,654   $        26,809   $       119,068    $       100,936
                                       ===============   ===============   ===============    ===============

Net earnings per share
   Basic                               $           .74   $           .63   $          2.79    $          2.38
                                       ===============   ===============   ===============    ===============
   Diluted                             $           .73   $           .62   $          2.75    $          2.34
                                       ===============   ===============   ===============    ===============

Average common shares outstanding
   Basic                                    42,684,157        42,503,581        42,604,268         42,429,711
                                       ===============   ===============   ===============    ===============
   Diluted                                  43,277,694        43,253,204        43,256,888         43,149,481
                                       ===============   ===============   ===============    ===============






                                    MOOG INC.
                     CONSOLIDATED SALES AND OPERATING PROFIT
                             (dollars in thousands)


                                              Three Months Ended                 Twelve Months Ended
                                        September 27,      September 29,      September 27,      September 29,
                                            2008               2007               2008               2007
                                       ---------------    ---------------    ---------------    ---------------
                                                                                    
Net Sales
   Aircraft Controls                   $       176,349    $       160,264    $       672,930    $       586,558
   Space and Defense Controls                   62,377             46,037            253,266            184,737
   Industrial Systems                          136,335            110,916            532,098            435,673
   Components                                   89,837             72,768            340,941            283,282
   Medical Devices                              25,948             23,430            103,431             67,849
                                       ---------------    ---------------    ---------------    ---------------
Net sales                              $       490,846    $       413,415    $     1,902,666    $     1,558,099
                                       ===============    ===============    ===============    ===============

Operating Profit and Margins
   Aircraft Controls                   $        13,449    $        17,493    $        54,979    $        61,198
                                                   7.6%              10.9%               8.2%              10.4%
   Space and Defense Controls                    5,963              5,548             29,261             24,211
                                                   9.6%              12.1%              11.6%              13.1%
   Industrial Systems                           16,708             13,797             73,467             57,470
                                                  12.3%              12.4%              13.8%              13.2%
   Components                                   16,073             10,699             60,644             44,530
                                                  17.9%              14.7%              17.8%              15.7%
   Medical Devices                               2,148              2,819              9,062              6,931
                                                   8.3%              12.0%               8.8%              10.2%
                                       ---------------    ---------------    ---------------    ---------------
Total operating profit                          54,341             50,356            227,413            194,340
                                                  11.1%              12.2%              12.0%              12.5%

Deductions from Operating Profit
   Interest expense                              9,683              9,123             37,739             29,538
   Equity-based compensation expense               857                569              4,551              3,299
   Corporate expenses and other                  4,892              4,298             17,088             17,752
                                       ---------------    ---------------    ---------------    ---------------
Earnings before Income Taxes           $        38,909    $        36,366    $       168,035    $       143,751
                                       ===============    ===============    ===============    ===============







                                    MOOG INC.
                           CONSOLIDATED BALANCE SHEETS
                             (dollars in thousands)


                                                      September 27,     September 29,
                                                          2008              2007
                                                     ---------------   ---------------
                                                                 
Cash                                                 $        86,814   $        83,856
Receivables                                                  517,361           431,978
Inventories                                                  408,295           359,250
Other current assets                                          77,915            61,767
                                                     ---------------   ---------------
        Total current assets                               1,090,385           936,851
Property, plant and equipment                                428,120           386,813
Goodwill and intangible assets                               635,490           620,349
Other non-current assets                                      73,252            62,166
                                                     ---------------   ---------------
        Total assets                                 $     2,227,247   $     2,006,179
                                                     ===============   ===============


Notes payable                                        $         7,579   $         3,354
Current installments of long-term debt                         1,487             2,537
Contract loss reserves                                        20,536            12,362
Other current liabilities                                    347,491           301,975
                                                     ---------------   ---------------
        Total current liabilities                            377,093           320,228
Long-term debt                                               661,994           611,633
Other long-term liabilities                                  193,750           197,106
                                                     ---------------   ---------------
        Total liabilities                                  1,232,837         1,128,967
Shareholders' equity                                         994,410           877,212
                                                     ---------------   ---------------
        Total liabilities and shareholders' equity   $     2,227,247   $     2,006,179
                                                     ===============   ===============